• Matías Baldini, María N Chiapella, Alejandra Fernandez, Sergio Guardia, Eduardo L De Vito, and Hernando Sala.
• Laboratorio de Función Pulmonar y Sueño, Hospital Nacional Profesor Dr. Alejandro Posadas, El Palomar, Buenos Aires, Agentina. E-mail: mbaldini@intramed.net.
• Medicina (B Aires). 2020 Jan 1; 80 (4): 359-370.

AbstractThe diffusing capacity for carbon monoxide (DLCO) is, after spirometry the standard and noninvasive pulmonary function test of greater clinical use. However, there are substantial errors in the interpretation of the physiological significance of the DLCO, its derived measures and, therefore the clinical significance of its alterations. In addition to the use of different nomenclatures, other sources of confusion have contributed to some negative view of the test. The technical aspects of the DLCO test have the advantage of being well standardized. But unlike what happens with other pulmonary function tests where we have reference values which allow us to determine their "normality or abnormality", it is difficult to apply this route of analysis in the case of DLCO. The central fact in the analysis of DLCO, transference factor for CO (KCO), and alveolar volume (VA) is that for a correct interpretation it is necessary to think about the mechanism by which the pathology induces change. A KCO of 100% can be considered normal in some circumstances or pathological in others and, for the moment, the automated study report cannot discriminate. This article will address the principles of the DLCO test; present different models of analysis submit concrete examples and provide guidelines for their correct interpretation. It is considered essential to carry out an integrated analysis of the DLCO test in relation to other functional tests and clinical data.

9 keywords...

hide…